Skip to main content
Back
Watch Compare

Neurogene Inc.

Data quality: 100%
NGNE
Nasdaq Manufacturing Chemicals
$20.99
▼ $0.62 (-2.87%)
Mkt Cap: 326.90 M
Price
$20.99
Mkt Cap
326.90 M
Day Range
$20.76 — $21.70
52-Week Range
$8.05 — $37.27
Volume
68,686
Open $21.59
50D / 200D Avg
$19.77
6.19% above
50D / 200D Avg
$21.29
1.41% below

Quick Summary

Key Takeaways

Negative free cash flow of -78.36 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-33.54%
Above sector avg (-53.41%)
ROIC-29.42%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio18.39
Interest Coverage-20665.60

Valuation

PE (TTM)
-3.62
Below sector avg (-1.48)
P/B Ratio1.23
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -3.6 -1.5
P/B 1.2 1.6
ROE % -33.5 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

BBC logo BBC Virtus Biotech Clinical Trials ETF
0.86% weight
MSGCX MSGCX
0.20% weight
MSGAX MSGAX
0.20% weight
MSGRX MSGRX
0.20% weight
MSGGX MSGGX
0.20% weight
MISGX MISGX
0.20% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -100.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -90.35 M
ROE -33.54% ROA -30.88%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -78.36 M
ROIC -29.42% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 18.39
Interest Coverage -20665.60 Asset Turnover 0.00
Working Capital 255.81 M Tangible Book Value 265.54 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.62 Forward P/E N/A
P/B Ratio 1.23 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -23.97%
Market Cap 326.90 M Enterprise Value 255.90 M
Per Share
EPS (Diluted TTM) -4.24 Revenue / Share 0.00
FCF / Share -5.03 OCF / Share -4.96
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 86.72%
SBC-Adj. FCF -91.65 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 925,000.0 — — —
Net Income -90.35 M -75.14 M -36.32 M -57.56 M -60.69 M
EPS (Diluted) -4.24 -4.28 2.93 -1.04 -1.10
Gross Profit — — — — —
Operating Income -103.33 M -82.61 M -55.58 M -59.10 M -60.70 M
EBITDA — — — — —
R&D Expenses 75.01 M 60.92 M 44.39 M 41.13 M —
SG&A Expenses — — — — —
D&A 3.04 M 3.20 M 3.26 M 1.56 M 1.31 M
Interest Expense 5,000.0 12,000.0 12,000.0 1.58 M —
Income Tax 0.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 288.60 M 335.73 M 222.57 M 115.95 M 163.26 M
Total Liabilities 23.72 M 25.36 M 36.55 M 21.62 M 20.40 M
Shareholders' Equity 264.89 M 310.38 M 186.02 M 94.33 M 142.86 M
Total Debt — — — — —
Cash & Equivalents 103.85 M 136.59 M 148.21 M 37.89 M 142.47 M
Current Assets 271.77 M 315.92 M 200.35 M 99.13 M 143.99 M
Current Liabilities 16.41 M 15.16 M 22.97 M 11.06 M 8.64 M